MedTrace Logo

Breathe-Easy: Hayfever Care for Patients With Seasonal Allergic Rhinitis

NCT06765239 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2025-01-09

No results posted yet for this study

Summary

This waitlist-controlled trial aims to evaluate the therapeutic effectiveness of Hayfever Care by assessing disease-specific symptoms over a 4-week period. Additionally, the study examines the tolerability and safety of the solution.

Conditions

  • Hayfever
  • Allergy Pollen
  • Allergic Rhinitis

Interventions

DIETARY_SUPPLEMENT

Hayfever Care

Powdered natural food supplement provided as a decoction, to be taken twice daily. Personalized Diet and Nutrition Guidance along with Lifestyle Advice

OTHER

Wait-list Control

Personalized Diet and Lifestyle Advice

Sponsors & Collaborators

  • Mettle Networks

    collaborator UNKNOWN

  • Innowage Limited

    lead INDUSTRY

Principal Investigators

  • Sandeep Shinde · Mettle Networks

  • Dr. Pradyuman S Rathore · Innowage, India

  • Dr Mridu Sharma · Gyansanjeevani India

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-24
Primary Completion
2024-06-06
Completion
2024-06-15

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06765239 on ClinicalTrials.gov